SSA
DERM

Schonfeld Strategic Advisors’s Dermira, Inc. DERM Stock Holding History

Schonfeld Strategic Advisors’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12,974
Closed -$442K – 845
2017
Q1 		$442K Buy
+12,974
New +$419K 0.04% 391

Other funds holding DERM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schonfeld Strategic Advisors's DERM Position: Q2 2017 in Review

Schonfeld Strategic Advisors sold out of Dermira, Inc. (DERM) in Q2 2017, closing a stake of 12,974 shares — an estimated $442K sold.

Schonfeld Strategic Advisors first reported a position in DERM in Q1 2017 and held it in 1 quarter. The position peaked at $442K in Q1 2017. 121 funds tracked by Wall St. Rank hold DERM as of Q2 2017.

  • Schonfeld Strategic Advisors reported no remaining Dermira, Inc. position as of Q2 2017 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 12,974 Dermira, Inc. shares in Q2 2017, an estimated $442K.
  • Schonfeld Strategic Advisors first reported a position in Dermira, Inc. in Q1 2017 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Dermira, Inc. position peaked at $442K in Q1 2017.
  • 121 funds tracked by Wall St. Rank held Dermira, Inc. as of Q2 2017.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.